hartil amlo capsule 10 mg + 5 mg
egis pharmaceuticals plc - ramiprilum + amlodipinum - capsule - 10 mg + 5 mg
hartil amlo capsule 2,5 mg + 2,5 mg
egis pharmaceuticals plc - ramiprilum + amlodipinum - capsule - 2,5 mg + 2,5 mg
hartil amlo capsule 5 mg + 10 mg
egis pharmaceuticals plc - ramiprilum + amlodipinum - capsule - 5 mg + 10 mg
hartil amlo capsule 5 mg + 5 mg
egis pharmaceuticals plc - ramiprilum + amlodipinum - capsule - 5 mg + 5 mg
gefitinib mylan
mylan pharmaceuticals limited - gefitinib - carcinom, pulmonar non-celulă mică - antineoplastic agents, protein kinase inhibitors - gefitinib mylan este indicat în monoterapie pentru tratamentul pacienților adulți cu avansat local sau metastatic non‑cancer pulmonar cu celule mici (nsclc), cu activarea mutații egfr‑tk.
nitromint spray sublingual 0,4 mg/doza
egis pharmaceuticals plc - nitroglycerinum - spray sublingual - 0,4 mg/doza
nebinorm 5 mg
glenmark pharmaceuticals s.r.o. - republica ceha - nebivololum - compr. - 5mg - agenti betablocanti betablocante selective
egiramlon 2,5 mg/2,5 mg
egis pharmaceuticals plc - ungaria - combinatii (ramiprilum + amlodipinum) - caps. - 2,5mg/2,5mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu
egiramlon 5 mg/5 mg
egis pharmaceuticals plc - ungaria - combinatii (ramiprilum + amlodipinum) - caps. - 5mg/5mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu
egiramlon 5 mg/10mg
egis pharmaceuticals plc - ungaria - combinatii (ramiprilum + amlodipinum) - caps. - 5mg/10mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu